المنتج | التاريخ | معلومات السلامة | المرفقات |
---|---|---|---|
Arzerra® (ofatumumab) | 2014-07-20 | change to safety information regarding update to hepatitis B virus reactivation warning . |
|
Arzerra® (ofatumumab) | 2014-07-20 | Safety update on a fatal infusion reaction reported in a patient with Chronic lymphocytic leukemia (CLL) who was treated with intravenous ofatumumab . |